HK1151045A1 - 液體免疫球蛋白 產品 - Google Patents

液體免疫球蛋白 產品

Info

Publication number
HK1151045A1
HK1151045A1 HK11105138.9A HK11105138A HK1151045A1 HK 1151045 A1 HK1151045 A1 HK 1151045A1 HK 11105138 A HK11105138 A HK 11105138A HK 1151045 A1 HK1151045 A1 HK 1151045A1
Authority
HK
Hong Kong
Prior art keywords
product
immunoglobulin
lgg
iga
exchange chromatography
Prior art date
Application number
HK11105138.9A
Other languages
English (en)
Inventor
Inga Laursen
Brge Teisner
Original Assignee
Csl Behring Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26150417&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1151045(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Csl Behring Ag filed Critical Csl Behring Ag
Publication of HK1151045A1 publication Critical patent/HK1151045A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591—Stabilisation, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK11105138.9A 1998-06-09 2011-05-24 液體免疫球蛋白 產品 HK1151045A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98201909 1998-06-09
US10205598P 1998-09-28 1998-09-28

Publications (1)

Publication Number Publication Date
HK1151045A1 true HK1151045A1 (zh) 2012-01-20

Family

ID=26150417

Family Applications (2)

Application Number Title Priority Date Filing Date
HK11105137.0A HK1151044A1 (en) 1998-06-09 2011-05-24 Process for manufacturing immunoglobulins for intravenous administration and other immunoglobulin-like products
HK11105138.9A HK1151045A1 (zh) 1998-06-09 2011-05-24 液體免疫球蛋白 產品

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK11105137.0A HK1151044A1 (en) 1998-06-09 2011-05-24 Process for manufacturing immunoglobulins for intravenous administration and other immunoglobulin-like products

Country Status (23)

Country Link
EP (4) EP2270044B1 (zh)
JP (1) JP5478519B2 (zh)
KR (1) KR100501263B1 (zh)
CN (1) CN1196714C (zh)
AT (1) ATE277950T1 (zh)
AU (1) AU753468B2 (zh)
BR (1) BR9911131A (zh)
CA (1) CA2330170C (zh)
CZ (1) CZ297199B6 (zh)
DE (1) DE69920693T2 (zh)
DK (1) DK1084147T3 (zh)
ES (1) ES2229784T3 (zh)
HK (2) HK1151044A1 (zh)
HU (1) HU228076B1 (zh)
ID (1) ID27417A (zh)
IL (1) IL140155A (zh)
NZ (1) NZ509135A (zh)
PL (1) PL196770B1 (zh)
PT (1) PT1084147E (zh)
RU (1) RU2197500C2 (zh)
SK (1) SK288128B6 (zh)
TR (1) TR200100303T2 (zh)
WO (1) WO1999064462A1 (zh)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2158776B1 (es) * 1999-04-13 2002-03-16 Apc Europ S A Procedimiento para la obtencion de gammaglobulinas de origen animal y aplicaciones correspondientes.
AUPQ026799A0 (en) * 1999-05-10 1999-06-03 Csl Limited Method of increasing protein stability by removing immunoglobulin aggregates
WO2001066124A2 (en) * 2000-03-10 2001-09-13 Medinnova Sf Composition for the treatment of heart failure
SE0001128D0 (sv) * 2000-03-30 2000-03-30 Amersham Pharm Biotech Ab A method of producing IgG
ES2184594B1 (es) * 2001-01-17 2004-01-01 Probitas Pharma Sa Procedimiento para la produccion de gammaglobulina g humana inactivada de virus.
FR2824568B1 (fr) 2001-05-11 2004-04-09 Lab Francais Du Fractionnement Procede de preparation de concentres d'immunoglobulines humaines a usage therapeutique
US20030223985A1 (en) * 2002-05-29 2003-12-04 The Lauridsen Group. Incorporated Globulin protein to lower cholesterol in humans
HUE027134T2 (en) 2002-09-11 2016-10-28 Chugai Pharmaceutical Co Ltd Method for protein purification
JPWO2004087761A1 (ja) * 2003-03-31 2006-07-27 麒麟麦酒株式会社 ヒトモノクローナル抗体およびヒトポリクローナル抗体の精製
EP1532983A1 (en) 2003-11-18 2005-05-25 ZLB Bioplasma AG Immunoglobulin preparations having increased stability
NZ576986A (en) 2004-01-30 2010-12-24 Shire Pharmaceuticals Ireland Ltd Production and purification of recombinant arylsulfatase A
US20070244305A1 (en) * 2004-01-30 2007-10-18 Suomen Punainen Risti Veripalvelu Process for The Manufacture of Virus Safe Immunoglobulin
AU2005229674B2 (en) * 2004-11-18 2010-11-04 Kedrion Melville Inc. Low concentration solvent/detergent process of immuneglobulin with pre-treatment
TWI391399B (zh) 2005-05-25 2013-04-01 Hoffmann La Roche 測定溶離多肽之鹽濃度之方法
AU2006296399B2 (en) 2005-09-30 2011-01-20 Medimmune Limited Interleukin-13 antibody composition
US9309316B2 (en) 2005-12-20 2016-04-12 Bristol-Myers Squibb Company Stable subcutaneous protein formulations and uses thereof
FR2895263B1 (fr) 2005-12-26 2008-05-30 Lab Francais Du Fractionnement Concentre d'immunoglobines g (lg) appauvri en anticorps anti-a et anti-b, et en igg polyreactives
ES2744499T3 (es) 2006-04-04 2020-02-25 Chiesi Farm Spa Un proceso para la concentración de un polipéptido
RU2303995C1 (ru) * 2006-04-28 2007-08-10 Халлар Абдумуслимович Алиханов Средство, обладающее иммунорегуляторным свойством и его применение для лечения аутоиммунных заболеваний
LT2061803T (lt) 2006-08-28 2019-11-25 Ares Trading Sa Fc turinčių baltymų gryninimo būdas
DE102007001521A1 (de) * 2007-01-10 2008-07-17 Matthias, Torsten, Dr. Verwendung von Cohn-Oncley-Fraktionen II und II/III zur Behandlung des systemischen Lupus erythematodes
SI2215117T2 (en) 2007-10-30 2018-04-30 Genentech, Inc. Purification of the antibody by cation exchange chromatography
US8883146B2 (en) 2007-11-30 2014-11-11 Abbvie Inc. Protein formulations and methods of making same
ES2406029T3 (es) 2008-04-15 2013-06-05 Grifols Therapeutics Inc. Ultrafiltración/diafiltración en dos fases
FR2939667B1 (fr) 2008-12-17 2012-01-27 Fractionnement Et Des Biotechonologies Lab Franc Composition d'immunoglobine g comme medicament pour le traitement de l'ictere neonatal par incompatibilite foetomaternelle dans le systeme abo
MY157239A (en) 2009-05-27 2016-05-13 Baxalta Inc A method to produce a highly concentrated immunoglobulin preparation for subcutaneous use
WO2011090720A2 (en) * 2009-12-29 2011-07-28 Dr. Reddy's Laboratories Ltd Purification of proteins
KR101912169B1 (ko) 2010-02-04 2018-10-26 체에스엘 베링 아게 면역글로불린 제제
EP2361636A1 (en) 2010-02-26 2011-08-31 CSL Behring AG Immunoglobulin preparation and storage system for an immunoglobulin preparation
GB201006753D0 (en) * 2010-04-22 2010-06-09 Biotest Ag Process for preparing an immunolobulin composition
RU2467783C2 (ru) * 2010-07-30 2012-11-27 Закрытое акционерное общество "БиоХимМак СТ" Способ хроматографического выделения иммуноглобулина
CA2823005C (en) 2010-12-30 2019-07-09 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Glycols as pathogen inactivating agents
PL3318571T3 (pl) 2011-03-16 2021-07-05 F. Hoffmann-La Roche Ag Chromatografia jonowymienna o ulepszonej selektywności do rozdzielania monomerów, agregatów i fragmentów polipeptydowych przez modulację fazy ruchomej
FR2974301B1 (fr) 2011-04-20 2013-08-23 Lab Francais Du Fractionnement Procede de preparation d'un produit plasmatique deplete en un ou plusieurs facteurs thrombogenes
IL212911A0 (en) * 2011-05-16 2011-07-31 Omrix Biopharmaceuticals Ltd Immunoglobulin reduced in thrombogenic contaminants and preparation thereof
US10336992B2 (en) 2011-07-08 2019-07-02 Shire Human Genetic Therapies, Inc. Methods for purification of arylsulfatase A
MY165164A (en) * 2011-08-26 2018-02-28 Baxalta Inc Method for reducing the thromboembolic potential of a plasma-derived immunoglobulin composition
CN102532307B (zh) * 2012-02-22 2013-06-12 成都蓉生药业有限责任公司 一种制备人免疫球蛋白的方法
DK3590960T3 (da) 2012-02-29 2023-04-24 Takeda Pharmaceuticals Co Igg-stimuleret remyelinisering af perifere nerver
EP2636684A1 (en) 2012-03-09 2013-09-11 CSL Behring AG Prevention of infection
EP2636681A1 (en) 2012-03-09 2013-09-11 CSL Behring AG Process for enriching IgA
DK2822967T3 (da) 2012-03-09 2019-10-07 Csl Behring Ag Compositions comprising secretory - like immunoglobulins
ES2381828B1 (es) * 2012-03-20 2012-11-16 Grifols, S.A. PROCEDIMIENTO PARA OBTENER UNA COMPOSICION DE IgG MEDIANTE TRATAMIENTO TERMICO
SG11201407801VA (en) 2012-05-31 2014-12-30 Agency Science Tech & Res Methods for use of mixed multifunctional surfaces for reducing aggregate content in protein preparations
EP2855504B1 (en) 2012-05-31 2018-10-24 Agency For Science, Technology And Research Chromatographic purification of immunoglobulin g preparations with particles having multimodal functionalities
EP2682168A1 (en) 2012-07-02 2014-01-08 Millipore Corporation Purification of biological molecules
JP6427502B2 (ja) 2013-01-09 2018-11-21 シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド アリールスルファターゼａの精製方法
AU2013203043B2 (en) 2013-03-15 2016-10-06 Takeda Pharmaceutical Company Limited Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs
WO2014186310A1 (en) 2013-05-13 2014-11-20 Momenta Pharmaceuticals, Inc. Methods for the treatment of neurodegeneration
KR102382662B1 (ko) 2013-07-01 2022-04-06 체에스엘 베링 아게 방법
KR20160029840A (ko) 2013-07-05 2016-03-15 라보라토이레 프란카이즈 듀 프락티온네먼트 에트 데스 바이오테크놀로지스 친화성 크로마토그래피 매트릭스
US20160257754A1 (en) 2013-10-16 2016-09-08 Momenta Pharmaceuticals Inc. Sialylated glycoproteins
CN103665100A (zh) * 2014-01-03 2014-03-26 华兰生物工程重庆有限公司 低温乙醇提取静注人免疫球蛋白的方法
EP3118209B1 (en) 2014-03-11 2020-02-19 Green Cross Holdings Corporation Method for purifying immunoglobulin
FR3018450B1 (fr) 2014-03-11 2016-04-15 Lab Francais Du Fractionnement Procede de preparation de proteines plasmatiques humaines
EP3131589B1 (en) * 2014-04-15 2023-05-17 Boehringer Ingelheim International GmbH Method and use for continuously inactivating a virus during manufacture of a biological product
CN104004090A (zh) * 2014-06-12 2014-08-27 新疆德源生物工程有限公司 一种人免疫球蛋白的制备方法
CN104356231B (zh) * 2014-11-10 2017-08-08 北海开元生物科技有限公司 一种有效去除人免疫球蛋白多聚体的方法
US9556253B2 (en) 2014-12-02 2017-01-31 Hemarus Therapeutics Limited Process for increased yield of immunoglobulin from human plasma
FR3035971A1 (fr) 2015-05-07 2016-11-11 Lab Francais Du Fractionnement Composition enrichie en immunoglobulines polyclonales anti-a et/ou anti-b
KR101657690B1 (ko) * 2015-06-05 2016-09-19 주식회사 녹십자홀딩스 혈장 유래 b형 간염 사람 면역글로불린 제제의 제조방법
CN105950576A (zh) * 2016-05-26 2016-09-21 成都远睿生物技术有限公司 一种从牛血中提取多种蛋白的方法
CN107880116B (zh) * 2016-09-30 2023-02-03 盖立复集团公司 用于制备免疫球蛋白的方法
FR3064485A1 (fr) 2017-03-31 2018-10-05 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Traitement d'une infection par le virus respiratoire syncytial
FR3064484A1 (fr) 2017-03-31 2018-10-05 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Composition d'immunoglobulines utiles pour traiter des infections virales
FR3064486A1 (fr) 2017-03-31 2018-10-05 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Prevention d'une infection par le virus respiratoire syncytial dans les voies respiratoires superieures
KR20190047376A (ko) 2017-10-27 2019-05-08 주식회사 녹십자 개선된 면역글로불린의 정제방법
CN109776675A (zh) * 2017-11-10 2019-05-21 北京博莱得利生物技术有限责任公司 两步离子交换层析法制备犬免疫球蛋白的方法
CN112574296B (zh) * 2020-12-30 2023-05-19 中国医学科学院输血研究所 一种模拟IVIg的多人份混合人血浆IgG样品的分离纯化方法
KR20230148961A (ko) * 2022-04-19 2023-10-26 에스케이플라즈마 주식회사 면역글로불린 정제방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2364792A1 (de) * 1973-01-15 1974-07-18 South African Inventions Verfahren zum reinigen von gammaglobulin
US4296027A (en) * 1977-08-31 1981-10-20 The Regents Of The University Of Minnesota Pure intravenous human and animal gamma globulins
US4314997A (en) 1980-10-06 1982-02-09 Edward Shanbrom Purification of plasma protein products
US4315919A (en) 1980-10-06 1982-02-16 Edward Shanbrom Depyrogenation process
US4764369A (en) 1983-07-14 1988-08-16 New York Blood Center Inc. Undenatured virus-free biologically active protein derivatives
NZ216094A (en) * 1985-05-15 1989-06-28 Commw Serum Lab Commission Method for purification of an immunoglobulin
DE4118912C1 (zh) * 1991-06-08 1992-07-02 Biotest Pharma Gmbh, 6072 Dreieich, De
FR2706466B1 (fr) * 1993-06-14 1995-08-25 Aetsrn Concentré d'immunoglobulines G à usage thérapeutique et procédé de production dudit concentré.

Also Published As

Publication number Publication date
DK1084147T3 (da) 2004-10-25
HU228076B1 (en) 2012-10-29
PL344671A1 (en) 2001-11-19
JP5478519B2 (ja) 2014-04-23
CN1311797A (zh) 2001-09-05
EP2270044B1 (en) 2014-11-05
KR100501263B1 (ko) 2005-07-18
CZ20004534A3 (en) 2001-06-13
RU2001101454A (ru) 2003-01-20
RU2197500C2 (ru) 2003-01-27
DE69920693T2 (de) 2005-11-03
IL140155A (en) 2005-12-18
EP2272870B1 (en) 2013-05-08
CA2330170C (en) 2010-11-02
CA2330170A1 (en) 1999-12-16
PT1084147E (pt) 2005-01-31
EP1084147A1 (en) 2001-03-21
HUP0101988A3 (en) 2004-10-28
IL140155A0 (en) 2002-02-10
CZ297199B6 (cs) 2006-09-13
AU753468B2 (en) 2002-10-17
TR200100303T2 (tr) 2001-06-21
KR20010052733A (ko) 2001-06-25
SK288128B6 (sk) 2013-10-02
HUP0101988A2 (hu) 2001-09-28
JP2011102314A (ja) 2011-05-26
BR9911131A (pt) 2001-03-06
PL196770B1 (pl) 2008-01-31
WO1999064462A1 (en) 1999-12-16
EP1084147B1 (en) 2004-09-29
ES2229784T3 (es) 2005-04-16
HK1151044A1 (en) 2012-01-20
EP1493751A1 (en) 2005-01-05
DE69920693D1 (de) 2004-11-04
AU4257299A (en) 1999-12-30
EP2270044A1 (en) 2011-01-05
ATE277950T1 (de) 2004-10-15
NZ509135A (en) 2002-10-25
SK18662000A3 (sk) 2001-07-10
ID27417A (id) 2001-04-05
CN1196714C (zh) 2005-04-13
EP2272870A1 (en) 2011-01-12

Similar Documents

Publication Publication Date Title
HK1151045A1 (zh) 液體免疫球蛋白 產品
AU749336B2 (en) Chromatographic method for high yield purification and viral inactivation of antibodies
Schwartz et al. Comparison of hydrophobic charge induction chromatography with affinity chromatography on protein A for harvest and purification of antibodies
US7186410B2 (en) Method for preparing human immunoglobulin concentrates for therapeutic use
EP0967995B1 (en) Composition comprising immunoglobulin
KR960006939A (ko) 분배제로서 카프릴산 나트륨을 사용하는 저온 알부민 분별법
IE860305L (en) Method for purifying antihemophilic factor
LT3333B (en) Chromatographic separation of plasma protein and concentrates obtained by this method
AU698334B2 (en) Method for isolation of highly pure von willebrand factor
RU93046317A (ru) Хиндроитиназа, способ ее получения и содержание ее фармацевтические композиции
US6955917B2 (en) Chromatographic method for high yield purification and viral inactivation of antibodies
CA2058676C (en) Process for isolating human albumin from supernatant iv, in particular iv-4, or from cohn's fraction v or from an analogous supernatant or fraction
CZ249295A3 (en) PROCESS FOR PREPARING ANTI-D IMMUNOGLOBULIN G AND PHARMACEUTICAL COMPOSITION CONTAINING ANTI -D IgG
CA2077888A1 (en) Method for purifying factor viii and preparations obtained
KR100297927B1 (ko) 인간에리스로포이에틴의정제방법
WO1998056822A3 (en) Process for the separation of specific immunoglobulins from standard plasma